A detailed history of Enterprise Financial Services Corp transactions in Amgen Inc stock. As of the latest transaction made, Enterprise Financial Services Corp holds 1,166 shares of AMGN stock, worth $368,456. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,166
Previous 1,149 1.48%
Holding current value
$368,456
Previous $326,000 11.66%
% of portfolio
0.23%
Previous 0.2%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $4,466 - $5,428
17 Added 1.48%
1,166 $364,000
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $117,496 - $141,832
-437 Reduced 27.55%
1,149 $326,000
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $4,602 - $5,192
-18 Reduced 1.12%
1,586 $456,000
Q3 2023

Oct 31, 2023

BUY
$218.65 - $271.46 $8,964 - $11,129
41 Added 2.62%
1,604 $431,000
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $16,927 - $20,016
-79 Reduced 4.81%
1,563 $347,000
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $5,193 - $6,329
-23 Reduced 1.38%
1,642 $396,000
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $231,778 - $294,502
-1,012 Reduced 37.8%
1,665 $437,000
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $9,651 - $10,885
43 Added 1.63%
2,677 $603,000
Q2 2022

Aug 09, 2022

BUY
$230.71 - $256.74 $253,319 - $281,900
1,098 Added 71.48%
2,634 $641,000
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $23,242 - $25,712
106 Added 7.41%
1,536 $371,000
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $135,039 - $154,540
-679 Reduced 32.2%
1,430 $322,000
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $279,559 - $327,537
1,317 Added 166.29%
2,109 $449,000
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $29,898 - $33,169
-128 Reduced 13.91%
792 $193,000
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $4,216 - $4,913
19 Added 2.11%
920 $229,000
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $1,947 - $2,319
9 Added 1.01%
901 $207,000
Q2 2020

Aug 04, 2020

BUY
$197.81 - $242.74 $8,110 - $9,952
41 Added 4.82%
892 $211,000
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $6,013 - $7,976
33 Added 4.03%
851 $172,000
Q4 2019

Jan 28, 2020

SELL
$189.21 - $243.2 $1,513 - $1,945
-8 Reduced 0.97%
818 $197,000
Q3 2019

Oct 31, 2019

BUY
$174.11 - $208.62 $15,495 - $18,567
89 Added 12.08%
826 $159,000
Q2 2019

Jul 30, 2019

SELL
$166.7 - $195.41 $3,334 - $3,908
-20 Reduced 2.64%
737 $135,000
Q4 2018

Jan 25, 2019

SELL
$178.4 - $208.25 $6,065 - $7,080
-34 Reduced 4.3%
757 $147,000
Q2 2018

Jul 27, 2018

SELL
$166.05 - $186.51 $2,490 - $2,797
-15 Reduced 1.86%
791 $146,000
Q1 2018

Apr 27, 2018

BUY
$169.43 - $198.0 $10,843 - $12,672
64 Added 8.63%
806 $137,000
Q4 2017

Jan 26, 2018

SELL
$168.79 - $188.59 $17,891 - $19,990
-106 Reduced 12.5%
742 $129,000
Q3 2017

Oct 27, 2017

BUY
$167.29 - $191.0 $141,861 - $161,968
848
848 $158,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Enterprise Financial Services Corp Portfolio

Follow Enterprise Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.